Screening blood donors for hepatitis C virus: the challenge to consider cost‐effectiveness

E-ISSN： 1537-2995|55|6|1143-1146

ISSN： 0041-1132

Source： TRANSFUSION, Vol.55, Iss.6, 2015-06, pp. : 1143-1146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost‐effectiveness of strategies for testing current hepatitis C virus infection

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1396-1404

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of sofosbuvir in the treatment of patients with hepatitis C

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. 4, 2015-04 ,pp. : 376-383

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of all‐oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 6, 2015-03 ,pp. : 544-563

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cost‐effectiveness of pretransplant sofosbuvir for preventing recurrent hepatitis C virus infection after liver transplantation

TRANSPLANT INTERNATIONAL (ELECTRONIC), Vol. 28, Iss. 9, 2015-09 ,pp. : 1055-1065

John Wiley & Sons Inc

Access to resources Recommend Favorite

Hepatitis C Virus Genotype in Blood Donors and Associated Liver Disease in Indonesia

Intervirology, Vol. 51, Iss. 6, 2009-03 ,pp. : 410-416

Karger

Access to resources Recommend Favorite